MRC Holland releases NXtec carrier panel
March 2026—MRC Holland launched the NXtec D028 Carrier Panel 1, a novel, DigitalMLPA assay for reliable carrier status analysis in genomically complex regions.
Webinars and Sponsored Roundtables — Register Now
Tuesday, June 9, 2026, 1:00–2:00 PM ET
In this webinar, we will examine how immune recognition after allogeneic HCT can influence leukemia relapse and disease progression. The session will highlight the clinical relevance of HLA loss of heterozygosity (LOH), approaches used for its detection, and how LOH findings may support transplant strategies, including considerations for donor selection in subsequent transplantation.
Webinar presenter Alberto Cardoso Martins Lima, PhD, Clinical consulting scientist in histocompatibility,
specializing in allogeneic hematopoietic cell transplantation (HCT) at IGEN/AFIP São Paulo and CHC/UFPR in Curitiba, Brazil
Moderated by: Bob McGonnagle, Publisher, CAP TODAY
Wednesday, June 24, 2026, 12:00–1:00 PM ET
Hear an expert discuss the expanded clinical utility of HER2 IHC scoring in metastatic breast cancer and its impact on your practice
Webinar presenter Michelle Shiller, DO, AP, CP, MGP, FACP, Baylor University Medical Center.
Moderated by: Bob McGonnagle, Publisher, CAP TODAY
Wednesday, July 15, 2026, 1:00-2:00 PM ET
Hear an expert discuss how to integrate Kappa and Lambda in situ hybridization testing into your standard hematopathology workflow to accurately assess B-cell and plasma cell clonality. You will also gain the skills to recognize testing pitfalls in challenging reactive versus neoplastic proliferations and apply ancillary tools to resolve complex cases.
Webinar presenter Xiaojun Wu, MD, PhD, Assistant professor, Director of Hematopathology Section at NCR of Johns Hopkins Medicine Department of Pathology, SOM at Johns Hopkins University
Moderated by: Bob McGonnagle, Publisher, CAP TODAY
Subspecialties
Interactive Product Guides
Marketplace
Biocartis and Mayo Clinic collaborate
March 2026—Biocartis has entered into a research collaboration with Mayo Clinic to develop a rapid sample-to-answer test aiming to decrease the time to treatment for breast cancer patients.
Natera acquires Foresight Dx
February 2026—Natera has completed a transaction to acquire cancer diagnostics company Foresight Diagnostics.
Randox type 1 diabetes risk test gets CE mark
February 2026—Randox’s type 1 diabetes risk test has received CE marking.
Revvity launches somatic cancer reference standards
February 2026—Revvity launched highly characterized somatic cancer reference standards developed in collaboration with the Medical Device Innovation Consortium and National Institute of Standards and Technology as part of the Somatic Reference Samples Initiative.
CellaVision bone marrow aspirate application gets CE mark
February 2026—CellaVision’s bone marrow aspirate application has received the CE mark as a class C product under the European Union in vitro diagnostic regulation.
Fujifilm and Voicebrook partner
February 2026—Fujifilm Healthcare Americas Corp. and Voicebrook are partnering to integrate Voicebrook’s VoiceOver Pro with Fujifilm’s Synapse Pathology, a picture archiving and communication system designed to streamline case management.
BD launches new FacsDiscover A8 configurations
February 2026—BD released new configurations of its FacsDiscover A8 cell analyzers.
Octave, Quest expand access to Octave MSDA test
February 2026—Octave Bioscience is collaborating with Quest Diagnostics to make the Octave Multiple Sclerosis Disease Activity test accessible through Quest’s nationwide specimen-collection network.
Diasorin gets clearance, waiver for fourplex panel
February 2026—Diasorin has received FDA 510(k) clearance and CLIA waiver for its first assay, a flu A/B, RSV, and COVID-19 panel, to be used on the Liaison Nes point-of-care molecular diagnostic platform.